INTRODUCTION: The purpose of this study was to test the hypothesis that malignant hyperthermia model mice (RyR1Y522S/wt) are more vulnerable to exercise-induced muscle injury and fatigability and adapt less to run training. METHODS: After 6 weeks of voluntary wheel running, we measured anterior crural muscle fatigability, muscle injury, and cytochrome oxidase (COX) and citrate synthase (CS). RESULTS: Although RyR1Y522S/wt mice ran without undergoing MH episodes, they ran 42% less distance than wild-type (WT) mice. Muscles from WT mice exhibited increased fatigue resistance and COX content after training. Muscles from RyR1Y522S/wt mice demonstrated no significant change in fatigability or COX and CS after training. However, muscles from RyR1Y522S/wt mice displayed less intrinsic fatigability and greater COX/CS content and muscle damage than WT mice. CONCLUSIONS: RyR1Y522S/wt mice can run without having rhabdomyolysis, and their inability to adapt to training appears to stem from intrinsic enhancement of mitochondrial enzymes and fatigue resistance.
INTRODUCTION: The purpose of this study was to test the hypothesis that malignant hyperthermia model mice (RyR1Y522S/wt) are more vulnerable to exercise-induced muscle injury and fatigability and adapt less to run training. METHODS: After 6 weeks of voluntary wheel running, we measured anterior crural muscle fatigability, muscle injury, and cytochrome oxidase (COX) and citrate synthase (CS). RESULTS: Although RyR1Y522S/wt mice ran without undergoing MH episodes, they ran 42% less distance than wild-type (WT) mice. Muscles from WT mice exhibited increased fatigue resistance and COX content after training. Muscles from RyR1Y522S/wt mice demonstrated no significant change in fatigability or COX and CS after training. However, muscles from RyR1Y522S/wt mice displayed less intrinsic fatigability and greater COX/CS content and muscle damage than WT mice. CONCLUSIONS:RyR1Y522S/wt mice can run without having rhabdomyolysis, and their inability to adapt to training appears to stem from intrinsic enhancement of mitochondrial enzymes and fatigue resistance.
Authors: G Chen; S Carroll; P Racay; J Dick; D Pette; I Traub; G Vrbova; P Eggli; M Celio; B Schwaller Journal: Am J Physiol Cell Physiol Date: 2001-07 Impact factor: 4.249
Authors: F Wappler; M Fiege; M Steinfath; K Agarwal; J Scholz; S Singh; J Matschke; J Schulte Am Esch Journal: Anesthesiology Date: 2001-01 Impact factor: 7.892
Authors: Imanuel Lerman; Brooke C Harrison; Kalev Freeman; Timothy E Hewett; David L Allen; Jeffrey Robbins; Leslie A Leinwand Journal: J Appl Physiol (1985) Date: 2002-06
Authors: M Davis; R Brown; A Dickson; H Horton; D James; N Laing; R Marston; M Norgate; D Perlman; N Pollock; K Stowell Journal: Br J Anaesth Date: 2002-04 Impact factor: 9.166
Authors: Gabriel Mettlach; Luis Polo-Parada; Lauren Peca; Clinton T Rubin; Florian Plattner; James A Bibb Journal: J Biomech Date: 2013-10-09 Impact factor: 2.712